AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 4th, 2017 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 4th, 2017 Company Industry JurisdictionThis Amended and Restated Employment Agreement (“Agreement”) is made this 3rd day of May 2017 (the “Effective Date”) between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Samarth Kulkarni, (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).